TRC105
Showing 1 - 25 of 29
Breast Cancer Trial in Birmingham (Letrozole, Everolimus, TRC105)
Active, not recruiting
- Breast Cancer
- Letrozole
- +2 more
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Jan 24, 2022
Solid Tumors Trial in Santa Monica (TRC105, Bevacizumab, Axitinib)
No longer available
- Solid Tumors
- TRC105
- +4 more
-
Santa Monica, CaliforniaUCLA
Jan 28, 2021
Lung Cancer Trial in Birmingham (TRC105)
Completed
- Lung Cancer
- TRC105
-
Birmingham, AlabamaUAB Comprehensive Cancer Center
Jun 24, 2021
Prostate Cancer Trial in Los Angeles (TRC105, Abiraterone, Enzalutamide)
Completed
- Prostate Cancer
- TRC105
- +2 more
-
Los Angeles, CaliforniaCedars Sinai Medical Center
Dec 4, 2020
Non Small Cell Lung Cancer, Lung Cancer Trial in Los Angeles (Osimertinib, Carotuximab)
Not yet recruiting
- Non Small Cell Lung Cancer
- Lung Cancer
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
May 27, 2022
Hepatocellular Carcinoma Trial in Birmingham, Cleveland, Houston (Carotuximab (TRC105), Sorafenib)
Completed
- Hepatocellular Carcinoma
- Carotuximab (TRC105)
- Sorafenib
-
Birmingham, Alabama
- +2 more
Jul 2, 2020
NSCLC Trial in Birmingham, Tampa (Carotuximab (TRC105), OPDIVO)
Completed
- Carcinoma, Non-Small-Cell Lung
- Carotuximab (TRC105)
- OPDIVO
-
Birmingham, Alabama
- +1 more
Jun 11, 2020
Advanced Soft Tissue Sarcoma Trial in United States (TRC105 and Pazopanib)
Completed
- Advanced Soft Tissue Sarcoma
- TRC105 and Pazopanib
-
Birmingham, Alabama
- +8 more
May 11, 2020
Renal Cell Carcinoma Trial in Worldwide (TRC105 and Axitinib, Axitinib)
Terminated
- Renal Cell Carcinoma
- TRC105 and Axitinib
- Axitinib
-
Birmingham, Alabama
- +38 more
Oct 15, 2020
Gestational Trophoblastic Neoplasia, Choriocarcinoma, Placental Site Trophoblastic Tumor Trial in Boston, Columbus, Dallas
Terminated
- Gestational Trophoblastic Neoplasia
- +3 more
- TRC105
- Bevacizumab
-
Boston, Massachusetts
- +2 more
Jul 9, 2019
Choriocarcinoma Trial in Boston (TRC105, Bevacizumab)
Completed
- Choriocarcinoma
- TRC105
- Bevacizumab
-
Boston, MassachusettsDana-Farber Cancer Insititue
May 17, 2019
Glioblastoma, Glioblastoma Multiforme Trial in Cincinnati, Cleveland, Columbus (TRC105, Bevacizumab)
Completed
- Glioblastoma
- Glioblastoma Multiforme
- TRC105
- Bevacizumab
-
Cincinnati, Ohio
- +3 more
May 21, 2019
Metastatic Breast Cancer Trial in Birmingham, Buffalo (TRC105, Capecitabine)
Hepatoma, Liver Tumors, Adenoma, Liver Cell Trial run by the NCI (TRC 105, Sorafenib)
Completed
- Hepatoma
- +4 more
- TRC 105
- Sorafenib
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jan 2, 2019
Adult Solid Tumor Trial in United States (TRC105 and Bevacizumab)
Completed
- Adult Solid Tumor
- TRC105 and Bevacizumab
-
Birmingham, Alabama
- +3 more
Nov 7, 2018
Prostate Cancer, Metastatic Castrate Resistant Prostate Cancer Trial run by the NCI (TRC105)
Completed
- Prostate Cancer
- Metastatic Castrate Resistant Prostate Cancer
- TRC105
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Apr 13, 2018
Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Carcinoma, Stage IV Renal Cell Cancer Trial in Australia, Taiwan, United
Completed
- Clear Cell Renal Cell Carcinoma
- +4 more
- Anti-Endoglin Chimeric Monoclonal Antibody TRC105
- +3 more
-
Duarte, California
- +29 more
Jul 30, 2018
Hepatocellular Carcinoma, Hepatocellular Cancer, Carcinoma, Hepatocellular Trial run by the NCI (TRC105)
Completed
- Hepatocellular Carcinoma
- +2 more
- TRC105
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 29, 2017
Urothelial Carcinoma, Ureteral Tumors, Ureter Cancer Trial run by the NCI (TRC105)
Completed
- Urothelial Carcinoma
- +4 more
- TRC105
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Nov 16, 2016
Lung Cancer, Thoracic Surgery, Anesthesia, Epidural Trial in Beijing (General anesthesia alone, Combined epidural-general
Completed
- Lung Cancer
- +4 more
- General anesthesia alone
- Combined epidural-general anesthesia
-
Beijing, Beijing, ChinaPeking University First Hospital
Aug 25, 2020
Tuberculosis, HIV Trial in Worldwide (Rifapentine (RPT), Isoniazid (INH), Pyridoxine (Vitamin B6))
Completed
- Tuberculosis
- HIV Infections
- Rifapentine (RPT)
- +2 more
-
La Jolla, California
- +44 more
Nov 2, 2021
NSCLC Trial in Worldwide (BI 695502, Avastin)
Completed
- Carcinoma, Non-Small-Cell Lung
- BI 695502
- Avastin
-
Anaheim, California
- +188 more
Dec 26, 2019
Diabetic Retinopathy, Chronic Kidney Diseases, Diabetes Trial in Kuala Lumpur (Empagliflozin 25 MG, OCT-A)
Unknown status
- Diabetic Retinopathy
- +2 more
- Empagliflozin 25 MG
- OCT-A
-
Kuala Lumpur, Wilayah Persekutuan, MalaysiaUKM Medical Centre
Dec 29, 2019